Form 4 for GMED GLOBUS MEDICAL INC
Accepted 2025-12-10 00:00:00 ET · period of report 2025-12-08 · accession 0001193125-25-314329 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-12-10 | 2025-12-08 | GMED | Paul David C | Executive COB, Dir, 10% | M - OptEx | $25.52 | +34.4K | 60.4K | +132% | +$877.2K |
| D | 2025-12-10 | 2025-12-08 | GMED | Paul David C | Executive COB, Dir, 10% | M - OptEx | $0.00 | -34.4K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2025-12-08 | M | A | 34,375 | $25.52 | 60,417 | D | — | — | |
| 2 | Derivative | Stock Option (Right to Buy Class A Common Stock) | 2025-12-08 | M | D | 34,375 | $0.00 | 0 | D | $25.52 · — to 2026-01-25 | 34,375 Class A Common Stock | (F1) These options were granted on January 25, 2016 and are fully vested. |